What are your research interests?
Medicinal Chemistry, Polymer Chemistry, Formulation, Advanced Therapeutics, Oral Drug delivery, Cell Membranes.
Why SCI? How did you first get involved and why would you encourage your peers to join?
SCI represents a great opportunity to learn more about the chemical industry, especially for scientists that are thinking of leaving academia.
It is also great to establish a network of world-class scientists working across different industries and for potential collaborations.
I was involved through a joint program with my Centre for Doctoral Training, where we were shown the breadth of what the SCI could offer.
SCI aims to be 'where science meets business'. What is the potential commercial application of your research?
My research project was scoped by my industry sponsor (Evonik GMBH) for a potential patent. The technology I have been developing is a new approach to sustained oral drug delivery, with the potential to be applied with a wide variety of drugs.
However, further studies (potentially a subsequent PhD) will be required to fully characterise this technology for in vivo application.
What do you hope to gain from your involvement with SCI?
I aim to establish a wide network across industries, to promote collaborations and simply to get to know great scientists and their projects.
I also want to learn more about different types of chemical industries, as currently my knowledge is limited to only some sectors.
Lorenzo Schiazza
Lucideon (Healthcare department) / University of Nottingham (School of Pharmacy)
External Links